The management of type 1 diabetes (T1D) has entered a new era of general population screening and preventive interventions. Although islet autoantibodies ...
In an era marked by armed conflicts, forced displacement, political instability, and ecological disasters, millions of ...
Brokerages maintained their bullish stance on large banks citing resilience, capital strength, and better liability profiles ...
The Gail Model is an online calculator that helps physicians estimate a patient’s risk of developing invasive breast cancer ...
Recording professionals have a new resource to help prepare their studios for natural disasters, emergencies and business ...
Coronary bifurcation lesions pose a significant challenge in interventional cardiology, accounting for approximately 15–25% ...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a ...
P2 Gold Inc. ("P2" or the "Company") (TSXV: PGLD) (OTCQB: PGLDF) reports that it has received the Notices of Extension for ...
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase 3 IMforte trial Zepzelca and atezolizumab ...
This important study used five metrics to compare the cost-effectiveness of intramural and extramural research funded by the National Institutes of Health in the United States between 2009 and 2019.
Climate change is accelerating environmental, social and governance (ESG) adoption by pushing companies to view ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback